Abstract:The oral and lung microbiomes connection through the oral–lung axis leads to an oral and lung health and disease intimate and bi‐directional relationship. In this mini‐review, we discuss opportunities for the airway microbiome to make a positive impact on the clinical management of respiratory health, aimed at personalization and assisted by multi‐omics data integration and computational modelling. The human respiratory system is constantly exposed to environmental stimuli, sometimes including toxicants, which can trigger dysregulated lung immune responses that lead to respiratory symptoms, impaired lung function and airway diseases. Evidence supports that the microbiome in the lungs has an indispensable role in respiratory health and disease, acting as a local gatekeeper that mediates the interaction between the environmental cues and respiratory health. Moreover, the microbiome in the lungs is intimately intertwined with the oral microbiome through the oral–lung axis. Here, we discuss the intricate three‐way relationship between (i) cigarette smoking, which has strong effects on the microbial community structure of the lung; (ii) microbiome dysbiosis and disease in the oral cavity; and (iii) microbiome dysbiosis in the lung and its causal role in patients suffering chronic obstructive pulmonary disease (COPD), a leading cause of morbidity and mortality worldwide. We highlight exciting outcomes arising from recently established interactions in the airway between environmental exposures, microbiome, metabolites–functional attributes and the host, as well as how these associations have the potential to predict the respiratory health status of the host through an airway microbiome health index. For completion, we argue that incorporating (synthetic) microbial community ecology in our contemporary understanding of lung disease presents challenges and also rises novel opportunities to exploit the oral–lung axis and its microbiome towards innovative airway disease diagnostics, prognostics, patient stratification and microbiota‐targeted clinical interventions in the context of current therapies.

Air-Pollution-Mediated Microbial Dysbiosis in Health and Disease: Lung-Gut Axis and Beyond

Impact of Environmental Pollutants on Gut Microbiome and Mental Health via the Gut–Brain Axis

Air pollution, dysbiosis and diseases: pneumonia, asthma, COPD, lung cancer and irritable bowel syndrome

The role of oral microbiome in respiratory health and diseases

Lung-gut axis of microbiome alterations following co-exposure to ultrafine carbon black and ozone

Lung microbiota: implications and interactions in chronic pulmonary diseases

Environmental exposures, the oral–lung axis and respiratory health: The airway microbiome goes on stage for the personalized management of human lung function

Diet, Microbiota and Gut-Lung Connection

Gut microbiome a promising target for management of respiratory diseases

Inhalation exposure to chemicals, microbiota dysbiosis and adverse effects on humans

Air pollution and endocrine disruptors induce human microbiome imbalances: A systematic review of recent evidence and possible biological mechanisms

Role of Microbiota on Lung Homeostasis and Diseases

Association of Intestinal Microbial Dysbiosis With Chronic Obstructive Pulmonary Disease

Air-pollutant particulate matter 2.5 (PM2.5)-induced inflammation and oxidative stress in diseases: Possible therapeutic approaches

The Influence of the Gut Microbiota on Host Health: A Focus on the Gut–Lung Axis and Therapeutic Approaches

Impact of air quality on the gastrointestinal microbiome: A review

Microbiome dysbiosis and epigenetic modulations in lung cancer: From pathogenesis to therapy

Respiratory diseases and gut microbiota: relevance, pathogenesis, and treatment

Gut microbiota: A new insight into lung diseases

Possible role of gut microbes and host’s immune response in gut–lung homeostasis

Microbiome effects on immunity, health and disease in the lung